INNOVIVA, INC. Increase (Decrease) in Deferred Revenue
INNOVIVA, INC. (INVA) reported Increase (Decrease) in Deferred Revenue of $1.75 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-05
- INNOVIVA, INC. increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was $2.34M, a 10.13% increase year-over-year.
- INNOVIVA, INC. increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was -$593.00K.
- INNOVIVA, INC. increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was -$9.30M, a 2374.08% decline year-over-year.
- INNOVIVA, INC. increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was $10.45M.
- INNOVIVA, INC. increase (decrease) in deferred revenue for fiscal 2025 was $3.14M.
- INNOVIVA, INC. increase (decrease) in deferred revenue for fiscal 2024 was -$151.00K.
- INNOVIVA, INC. increase (decrease) in deferred revenue for fiscal 2023 was -$817.00K.
- INNOVIVA, INC. increase (decrease) in deferred revenue for fiscal 2022 was -$755.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.75M 10-Q · filed 2026-08-05 | -$7.56M derived: sum of 3 quarters · filed 2026-08-05 | $2.89M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$593.00K 10-Q · filed 2026-05-06 | -$9.89M derived: sum of 2 quarters · filed 2026-05-06 | $552.00K derived: sum of 3 quarters · filed 2026-05-06 | $2.67M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$9.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.15M derived: sum of 2 quarters · filed 2026-02-25 | $3.27M derived: sum of 3 quarters · filed 2026-08-05 | $3.14M 10-K · filed 2026-02-25 |
| 2025-09-30 | $10.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $12.57M derived: sum of 2 quarters · filed 2026-08-05 | $12.45M 10-Q · filed 2025-11-05 | $12.85M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.00M 10-Q · filed 2026-08-05 | $2.41M derived: sum of 3 quarters · filed 2026-08-05 | $2.27M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$124.00K 10-Q · filed 2026-05-06 | $285.00K derived: sum of 2 quarters · filed 2026-05-06 | $147.00K derived: sum of 3 quarters · filed 2026-05-06 | $15.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $271.00K derived: sum of 2 quarters · filed 2026-02-25 | $139.00K derived: sum of 3 quarters · filed 2026-02-25 | -$151.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | -$138.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$270.00K derived: sum of 2 quarters · filed 2025-11-05 | -$560.00K 10-Q · filed 2025-11-05 | -$831.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$422.00K 10-Q · filed 2025-08-06 | -$693.00K derived: sum of 3 quarters · filed 2026-02-25 | -$2.40M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$290.00K 10-Q · filed 2025-05-07 | -$561.00K derived: sum of 2 quarters · filed 2026-02-25 | -$2.27M derived: sum of 3 quarters · filed 2026-02-25 | -$1.11M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.98M derived: sum of 2 quarters · filed 2026-02-25 | -$817.00K derived: sum of 3 quarters · filed 2026-02-25 | -$817.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | -$1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$546.00K derived: sum of 2 quarters · filed 2024-11-06 | -$546.00K 10-Q · filed 2024-11-06 | -$1.30M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $1.16M 10-Q · filed 2024-07-31 | $405.00K derived: sum of 3 quarters · filed 2025-02-26 | $405.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | -$755.00K derived: sum of 2 quarters · filed 2025-02-26 | -$755.00K derived: sum of 3 quarters · filed 2025-02-26 | |
| 2022-12-31 | -$755.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$755.00K derived: sum of 2 quarters · filed 2025-02-26 | -$755.00K 10-K · filed 2025-02-26 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-02 | |||
| 2021-12-31 | $0.00 10-K/A · filed 2024-03-05 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 | |||
| 2017-12-31 | -$2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$2.66M derived: sum of 2 quarters · filed 2018-02-23 | -$2.88M derived: sum of 3 quarters · filed 2018-02-23 | -$3.10M 10-K · filed 2018-02-23 |
| 2017-09-30 | -$221.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$442.00K derived: sum of 2 quarters · filed 2017-11-03 | -$663.00K 10-Q · filed 2017-11-03 | -$884.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2017-06-30 | -$221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$442.00K 10-Q · filed 2017-08-08 | -$663.00K derived: sum of 3 quarters · filed 2018-02-23 | -$884.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2017-03-31 | -$221.00K 10-Q · filed 2017-05-05 | -$442.00K derived: sum of 2 quarters · filed 2018-02-23 | -$663.00K derived: sum of 3 quarters · filed 2018-02-23 | -$885.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-12-31 | -$221.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$442.00K derived: sum of 2 quarters · filed 2018-02-23 | -$664.00K derived: sum of 3 quarters · filed 2018-02-23 | -$885.00K 10-K · filed 2018-02-23 |
| 2016-09-30 | -$221.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$443.00K derived: sum of 2 quarters · filed 2017-11-03 | -$664.00K 10-Q · filed 2017-11-03 | -$884.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | -$222.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$443.00K 10-Q · filed 2017-08-08 | -$663.00K derived: sum of 3 quarters · filed 2018-02-23 | -$885.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | -$221.00K 10-Q · filed 2017-05-05 | -$441.00K derived: sum of 2 quarters · filed 2018-02-23 | -$663.00K derived: sum of 3 quarters · filed 2018-02-23 | -$884.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | -$220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$442.00K derived: sum of 2 quarters · filed 2018-02-23 | -$663.00K derived: sum of 3 quarters · filed 2018-02-23 | -$885.00K 10-K · filed 2018-02-23 |
| 2015-09-30 | -$222.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$443.00K derived: sum of 2 quarters · filed 2016-11-03 | -$665.00K 10-Q · filed 2016-11-03 | -$935.00K derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | -$221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$443.00K 10-Q · filed 2016-08-04 | -$713.00K derived: sum of 3 quarters · filed 2017-02-28 | -$984.00K derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | -$222.00K 10-Q · filed 2016-05-05 | -$492.00K derived: sum of 2 quarters · filed 2017-02-28 | -$763.00K derived: sum of 3 quarters · filed 2017-02-28 | -$3.10M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | -$270.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$541.00K derived: sum of 2 quarters · filed 2017-02-28 | -$2.87M derived: sum of 3 quarters · filed 2017-02-28 | -$3.18M 10-K · filed 2017-02-28 |
| 2014-09-30 | -$271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$2.60M derived: sum of 2 quarters · filed 2015-11-05 | -$2.91M 10-Q · filed 2015-11-05 | -$3.37M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | -$2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$2.64M 10-Q · filed 2015-08-06 | -$3.10M derived: sum of 3 quarters · filed 2016-02-24 | -$3.52M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | -$308.00K 10-Q · filed 2015-05-08 | -$765.00K derived: sum of 2 quarters · filed 2016-02-24 | -$1.19M derived: sum of 3 quarters · filed 2016-02-24 | -$2.02M derived: sum of 4 quarters · filed 2016-02-24 |
| 2013-12-31 | -$457.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$885.00K derived: sum of 2 quarters · filed 2016-02-24 | -$1.71M derived: sum of 3 quarters · filed 2016-02-24 | $3.23M 10-K · filed 2016-02-24 |
| 2013-09-30 | -$428.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$1.25M derived: sum of 2 quarters · filed 2014-11-04 | $3.69M 10-Q · filed 2014-11-04 | $3.56M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | -$826.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $4.12M 10-Q · filed 2014-08-07 | $3.99M derived: sum of 3 quarters · filed 2015-02-27 | $2.54M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $4.95M 10-Q · filed 2014-05-07 | $4.82M derived: sum of 2 quarters · filed 2015-02-27 | $3.37M derived: sum of 3 quarters · filed 2015-02-27 | $1.94M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | -$128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$1.58M derived: sum of 2 quarters · filed 2015-02-27 | -$3.01M derived: sum of 3 quarters · filed 2015-02-27 | -$130.11M 10-K · filed 2015-02-27 |
| 2012-09-30 | -$1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | -$2.88M derived: sum of 2 quarters · filed 2013-11-01 | -$129.98M 10-Q · filed 2013-11-01 | -$134.59M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$128.53M 10-Q · filed 2013-08-01 | -$133.14M derived: sum of 3 quarters · filed 2014-03-03 | -$135.76M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | -$127.10M 10-Q · filed 2013-05-01 | -$131.71M derived: sum of 2 quarters · filed 2014-03-03 | -$134.33M derived: sum of 3 quarters · filed 2014-03-03 | -$140.03M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | -$4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$7.23M derived: sum of 2 quarters · filed 2014-03-03 | -$12.93M derived: sum of 3 quarters · filed 2014-03-03 | -$18.63M 10-K · filed 2014-03-03 |
| 2011-09-30 | -$2.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | -$8.32M derived: sum of 2 quarters · filed 2012-10-31 | -$14.03M 10-Q · filed 2012-10-31 | -$19.73M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | -$5.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | -$11.40M 10-Q · filed 2012-08-01 | -$17.10M derived: sum of 3 quarters · filed 2013-02-26 | -$22.80M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | -$5.70M 10-Q · filed 2012-05-02 | -$11.40M derived: sum of 2 quarters · filed 2013-02-26 | -$17.10M derived: sum of 3 quarters · filed 2013-02-26 | |
| 2010-12-31 | -$5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$11.40M derived: sum of 2 quarters · filed 2013-02-26 | -$21.80M 10-K · filed 2013-02-26 | |
| 2010-09-30 | -$5.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$16.10M 10-Q · filed 2011-11-02 | ||
| 2010-06-30 | -$10.40M 10-Q · filed 2011-08-03 | |||
| 2009-12-31 | $4.59M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |